Bibliografía
 

2.- Cardiac Catheterization and Angiography. Willian Grossman. Lea&Febiger. 1986. Tercera Edición.

3.-Clinical hypertension. Kaplan. Williams Wilkins. Baltimore. 1986 4ª Edicion.

4.-El corazón en la hipertensión arterial. J. Díez. Doyma. Barcelona. 1992.

5.- Hypertension. Pathophysiology, diagnosis and management. Laragh & Brenner. Raven Press. Nueva York. 1990.

6.- Syndromes of  atherosclerosis. Correlations of clinical imaging and pathology. Valentin Fuster. Futura Publising Company (American Heart Association). 1996.

7.- The 1988 Report of the Joint National Committe on Detection, Evaluation and treatment of High Blood Pressure. Arch Intern Med. 1988; 148: 1023-1038

8.-Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure: The fifth report. Arch Intern Med 1993; 153: 154-167.

9.- Dannenberg AL. et al. Incidence of hypertension in the Framingham study.. Am J Publ Health. 1988; 78: 676-682.

10.- Gifford RW, et al. Office evaluation of hypertension: A statement for health professionals by a writing group of the council for High Blood Pressure Research. Americam Heart Associaton. Circulation. 1989; 79: 721-731.

11.- Houston MC et al. Pathophysiology, clinical aspects, and treatment of hypertensive crises. Prog Cardiovasc Dis. 1989;32:99-108

12.- Frohlich ED . Mechanisms contributing to high blood pressure. Ann Intern Med. 1983;98:709-715.

13.-Ahmed MEK, Walker Jm, Beevers DG, et al. Lack of difference between malignant and accelerated hypertension. BMJ, 1986;292:235-240.

14.- Gifford RJ Jr. Management of hypertensive crisis. JAMA 1991;266: 829-837.

15.- Biller J, Godersky JC, Adams HP. Management of aneurysmal subaracnoid hemorrhage. Stroke 1988;19: 1300-1308.

16.- Tettenborn D, Dycka J, Volberg E, Düdden P. Prevention and treatment of delayed ischemic dysfuntion in patients with aneurysmal subaracnoid hemorrhage. Stroke 1990;21: supple. IV-85-90.

17.- Brott T, Reed RL, Intensive care for acute stroke in the comunity hospital setting: the first 24 hours. Stoke 1989;20: 694-697.

18.- Ziegler MG, Ruiz-Ramon,PJ. Antihypertensive Therapy. Pag 405-428; in The Pharmacologic Approach to the Critically Ill Patients. 3th Ed. Bart Chernow. Williams&Wilkins.1994.

19.- Gelmers HJ, Gorter K , de Weerdt CJ, Wieser HJA. A controlled trial of nimodipine in acute ischemic stroke. N Engl J Med.1988;318:203-206.

20.-Martinez-Vila E, Guillen F, Villanueva JA, et al. Placebo-controlled trial of nimodipine in the treatment of acute ischemic cerebral infarction.. Stroke. 1990;21:1023-1029.

21.-Psaty Bm, Smitth Ns, Siscovick DS et al. Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic rewiew and meta.analysis. JAMA.1997;277:739-745.

22.-Haude M, Stefen W, Erbel R, Meyer J. Sublingual administration of captopril versus nitroglycerin in patients with severe congestive heart failure. Int J Cardiol. 1990; 27:351-356. 

23.- Nienaber CA, von Kodolitsch Y, Nicolas V, et al. The diagnosis of thoracic aortic dissection by noninvasive imaging procedures. N Engl J Med. 1993;328:1-6

24.- Jespersen B, Eiskjaer H, Christiansen NO, et al. Malignant arterial hypertension relationship between blood pressure control and renal function during long term observation of patients with malignant nephroesclerosis. J Clin Hypertension 1987;3:409-418

25.-Elliot WJ, Webwe RR, Nelson, KS, et al. Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension. Circulation 1990;81:970-977

26.- Nightingale SL, New labeling for sodium nitroprusside emphasizes risk of cyanide toxicity. JAMA 1991; 265:847-851.

27.-Joint National Committee on detection, evaluation, and treatment of high blood pressure. The sixth report of the joint national committee on prevention, evaluation and treatment of high blood pressure(JNC VI). Arch Intern Med 1997;157:2413-2446.

28.-Cutler JA, Follmann D, Allender PS,. Randomized trials of sodium reduction: an overview. Am J Clin Nutr. 1997;65:643-651

29.- Whelton PK, He J, Cutler JA, et al. Effects of oral potassium reduction on blood pressure. Meta-analysis of randomimized controlled clinical trials. JAMA 1997;277:1624-1632.

30.- Franklin SS, Gustin IVW, Wong ND et al. Hemodynamic patterns of age-related changes in blood pressure. The Framimingham Heart study. Circulation 1997;96:308-315.

31.-Manolio TA, Cutler JA, Furberg CD, et al. Trends in pharmacologic management of hypertension in the United States. Arch Intern Med 1995;155:829-837.

32.-Gifford RW Jr. Antihypertensive therapy. Angiotensin converting enzyme inhibitors, angiotensin II receptor antagonists and calcium antagonists. Med Clin North Am 1997 (nov);81(6) 1319-1333.

33.-Elliott HL. Angiotensine II antagonists: efficacy, duration of action, comparison with other drugs. J Hum Hypertens. 1988;12:271-274.

34.-Pearce KA, Furberg CD, Psaty BM, Kirk J. Comparative cost-effectiveness of first-line drugs for uncomplicated hypertension. Am J Hypertens 1988;11: 618-629.